| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Ahmad Diaz, Faten |
| dc.contributor.author | Villanueva, Rafael |
| dc.contributor.author | Valdivia Vadell, Carolina |
| dc.contributor.author | Palomino-Doza, Julián |
| dc.contributor.author | Ruiz, Ada |
| dc.contributor.author | Azaro Pedrazzoli, Analía Beatriz |
| dc.contributor.author | Aguilar-Company, Juan |
| dc.contributor.author | Martín Pérez, Anastasio |
| dc.contributor.author | Escriva de Romaní Muñoz, Santiago Ignacio |
| dc.contributor.author | Alcalde Rodrigo, Maria |
| dc.contributor.author | Ruiz Camps, Isabel |
| dc.contributor.author | Bellet Ezquerra, Meritxell |
| dc.contributor.author | Reyes López, Victoria |
| dc.date.accessioned | 2019-08-08T06:29:19Z |
| dc.date.available | 2019-08-08T06:29:19Z |
| dc.date.issued | 2019-05-10 |
| dc.identifier.citation | Bellet M, Ahmad F, Villanueva R, Valdivia C, Palomino-Doza J, Ruiz A, et al. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication. Ther Adv Med Oncol. 2019;11:1758835919833867. |
| dc.identifier.issn | 1758-8340 |
| dc.identifier.uri | https://hdl.handle.net/11351/4251 |
| dc.description | Inhibidors de CDK; Càncer de mama; Palbociclib |
| dc.language.iso | eng |
| dc.publisher | SAGE Publications |
| dc.relation.ispartofseries | Therapeutic Advances in Medical Oncology;11 |
| dc.rights | Attribution-NonCommercial 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
| dc.source | Scientia |
| dc.subject | Mama - Càncer - Quimioteràpia |
| dc.subject | Quinases dependents de ciclina - Inhibidors |
| dc.subject | Medicaments - Interacció |
| dc.subject.mesh | Breast Neoplasms |
| dc.subject.mesh | /drug therapy |
| dc.subject.mesh | Cyclin-Dependent Kinase Inhibitor Proteins |
| dc.subject.mesh | /therapeutic use |
| dc.subject.mesh | Drug Interactions |
| dc.title | Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1177/1758835919833867 |
| dc.subject.decs | neoplasias de la mama |
| dc.subject.decs | /tratamiento farmacológico |
| dc.subject.decs | proteínas inhibidoras de cinasas dependientes de ciclinas |
| dc.subject.decs | /uso terapéutico |
| dc.subject.decs | interacciones farmacológicas |
| dc.relation.publishversion | https://journals.sagepub.com/doi/10.1177/1758835919833867 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Bellet M, Escrivá-de-Romaní S] Hospital Universitari Vall d'Hebron, Barcelona, Spain. Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. [Ahmad F, Alcalde M, Ruíz I] Vall d’Hebron Institut de Recerca, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Villanueva R] Institut Català d'Oncologia, Barcelona, Spain. Hospital Moisès Broggi, Barcelona, Spain. [Valdivia C] Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Palomino-Doza J] Hereditary Cardiopathies Unit, Hospital Universitario 12 de Octubre, Madrid, Spain. [Ruiz A] Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain. Institut Hospital de Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain. [Azaro A] Servei d’Oncologia Mèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. [Aguilar J] Servei d’Oncologia Mèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Martín A] Unitat de Cures Pal•liatives, Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Reyes V] Servei d’ Oncologia Radioteràpica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. |
| dc.identifier.pmid | 31205497 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |